Search Results

It can be important to include clinical variables not found in claims data when carrying out propensity score matching

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 13-13(1)

Publisher: Adis International

The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching: The Case of ESA Costs for the Treatment of Chemotherapy-Induced Anaemia

Authors: Polsky, Daniel; Eremina, Daria; Hess, Gregory; Hill, Jerrold; Hulnick, Scott; Roumm, Adam; Whyte, Joanna L.; Kallich, Joel

Source: PharmacoEconomics, Volume 27, Number 9, 1 September 2009 , pp. 755-765(11)

Publisher: Adis International

Methoxy polyethylene glycol-epoetin beta: worth waiting for or a novelty worn off?

Author: Schmidt, Rebecca J

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 9, June 2009 , pp. 1509-1514(6)

Publisher: Informa Healthcare

Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia

Authors: Tzekova, Valentina; Mihaylov, Georgi; Elezovic, Ivo; Koytchev, Rossen

Source: Current Medical Research and Opinion, Volume 25, Number 7, July 2009 , pp. 1689-1697(9)

Publisher: Informa Healthcare

Use and cost of erythropoiesis-stimulating agents in patients with cancer

Authors: Daniel, Gregory; Hurley, Dana; Whyte, Joanna L.; Willey, Vincent; Wilson, Marcus; Kallich, Joel

Source: Current Medical Research and Opinion, Volume 25, Number 7, July 2009 , pp. 1775-1784(10)

Publisher: Informa Healthcare

The cumulative costs using epoetin-α are 29% lower than those using darbepoetin-α in cancer chemotherapy patients

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 12-12(1)

Publisher: Adis International

Balancing act required when considering ESAs for cancer-related anaemia

Source: Reactions, Volume 1, Number 1251, 2009-05-09 , pp. 1-1(1)

Publisher: Adis International

Erythropoiesis Stimulating Agents and Techniques: A Challenge for Doping Analysts

Author: Jelkmann, W.

Source: Current Medicinal Chemistry, Volume 16, Number 10, April 2009 , pp. 1236-1247(12)

Publisher: Bentham Science Publishers

Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients

Authors: Bradbury, Brian D.; Critchlow, Cathy W.; Weir, Matthew R.; Stewart, Ron; Krishnan, Mahesh; Hakim, Raymond H.

Source: Nephrology Dialysis Transplantation, Volume 24, Number 3, 10 March 2009 , pp. 919-925(7)

Publisher: Oxford University Press

Epoetin-α: no QOL benefits in patients with solid tumours

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 574, 2009-03-21 , pp. 9-9(1)

Publisher: Adis International

Epoetin α: Pure red cell aplasia: case report

Source: Reactions, Volume 1, Number 1238, 2009-02-07 , pp. 13-13(1)

Publisher: Adis International

Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study

Authors: Canaud, Bernard; Mingardi, Giulio; Braun, Johann; Aljama, Pedro; Kerr, Peter G.; Locatelli, Francesco; Villa, Giuseppe; Van Vlem, Bruno; McMahon, Alan W.; Kerloguen, Ccile; Beyer, Ulrich

Source: Nephrology Dialysis Transplantation, Volume 23, Number 11, 19 November 2008 , pp. 3654-3661(8)

Publisher: Oxford University Press

Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand

Authors: Bell; Grimes; Gurney; Dalley; Blackwell; Fox; Jeffery

Source: Internal Medicine Journal, Volume 38, Number 10, October 2008 , pp. 751-757(7)

Publisher: Blackwell Publishing

Effect of epoetin alfa therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy

Authors: ICONOMOU, G.; KOUTRAS, A.; KARAIVAZOGLOU, K.; KALLIOLIAS, G.D.; ASSIMAKOPOULOS, K.; ARGYRIOU, A.A.; IFANTI, A.; KALOFONOS, H.P.

Source: European Journal of Cancer Care, Volume 17, Number 6, November 2008 , pp. 535-541(7)

Publisher: Blackwell Publishing

Preliminary data analysis of a European study have revealed increased mortality in patients who received epoetin-α for acute ischaemic stroke

Source: Reactions, Volume 1, Number 1221, 2008-09-27 , pp. 4-4(1)

Publisher: Adis International

Preliminary data analysis of a European study have revealed increased mortality in patients who received epoetin-α for acute ischaemic stroke

Source: Inpharma, Volume 1, Number 1657, 2008-09-27 , pp. 19-19(1)

Publisher: Adis International

FDA reviewing safety of epoetin alfa in stroke patients

Source: Reactions, Volume 1, Number 1222, 2008-10-04 , pp. 4-4(1)

Publisher: Adis International

ANEMIA AND RESPONSE TO EPOETIN ALFA: THE CAUSE OF ANEMIA MATTERS!

Author: Dharmarajan, T. S.

Source: Journal of the American Geriatrics Society, Volume 56, Number 8, August 2008 , pp. 1574-1575(2)

Publisher: Blackwell Publishing

Epoetin-α: Deep vein thrombosis in an elderly patient with myelodysplastic syndrome: case report

Source: Reactions, Volume 1, Number 1218, 2008-09-06 , pp. 16-16(1)

Publisher: Adis International

A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease

Authors: Roger, Simon D.; Suranyi, Michael G.; Walker, Rowan G.; COMFORT study group,

Source: Current Medical Research and Opinion, Volume 24, Number 8, August 2008 , pp. 2181-2187(7)

Publisher: Informa Healthcare